Acute Effect of Low-intensity Gamma rTMS on Cognitive and EEG Parameters in Adults With Mild Dementia by Alzheimer's Disease
Alzheimer Disease, Mild Dementia
About this trial
This is an interventional treatment trial for Alzheimer Disease
Eligibility Criteria
Inclusion Criteria: Both sexes Age over 65 years old Who give written informed consent Patients with a diagnosis compatible with mild dementia according to NINCDS-ADRDA (National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association, 1984) criteria. CDR 1 Preserved or corrected ability to see and hear Have a formal or informal caregiver Exclusion Criteria: Clinical diagnosis of a neurodegenerative disease other than mild dementia due to Alzheimer's disease Present an uncontrolled medical condition at the time of the assessment for admission to the protocol (diabetes, heart disease, hypertension, hypothyroidism, uncontrolled renal or hepatic insufficiency). Diagnosis of major depression and/or some other untreated psychiatric illness (calculated with GDS) Excessive alcohol use Current or recent (6 months) use of any neurostimulation methods Metal implants excluding dental Signs or symptoms of increased intracranial pressure History of having received electroconvulsive therapy. Suffering from epilepsy. Having a deep brain stimulator implanted. Having any metallic prosthesis in the head. Having a pacemaker Extensive tattoos Taking any of the following medications: Tricyclic antidepressants such as: imipramine, amitriptyline, doxepin, nostriptyline, matroptyline. Antivirals such as: foscarnet, ganciclovir, ritonavir, dissociative anesthetics such as: phencyclidine, ketamine, γ-hydroxybutyrate Other stimulant drugs such as: amphetamines, cocaine, MDMA (ecstasy)
Sites / Locations
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
Real low-intensity rTMS
Sham low-intensity rTMS
One 45 minutes session of stimulation. The stimulation coil will be located in the precuneus, located in the Pz area of the 10-20. The coil will emit a pulsed magnetic field at a frequency of 40 Hz with a magnetic field strength of 150 gauss.
One 45 minutes session of stimulation. The stimulation coil will be located in the precuneus, located in the Pz area of the 10-20. The coil will not emit any magnetic field.